India's auto sales volume will take 3-4 years to recover: SIAM

“Production has been slow to pick up due to supply chain disruption and weak demand,” said Rajan Wadhera, president, SIAM

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

It said work there would not be stopped, however, as the company wanted to learn to “live with the virus”

Domestic motorcycle production would gain some support from shift in demand but more benefit would accrue from the export market

Tesla has seen ups and downs but its shares have risen steadily since late 2019 as it met key production targets for its Model 3 car

The move is part of India’s effort to create ‘champion’ sectors to attract investment, generate jobs and boost manufacturing

Hengli Engineering was to invest Rs 250 crore and PMI Rs 1,000 crore in the auto sector

The automaker posted a consolidated fourth quarter net loss of Rs 98.94 billion, as coronavirus lockdowns across its markets ravaged sales

Mahindra, which owns a 75 per cent stake in SsangYong, rescued the sport-utility vehicle (SUV) maker from near-insolvency in 2010

For the first time, said FADA President Ashish Harsharaj Kale, the month of April witnessed zero retails